| Overcoming resistance to checkpoint blockade therapy by targeting PI3Kγ in myeloid cells O De Henau, M Rausch, D Winkler, LF Campesato, C Liu, DH Cymerman, ... Nature 539 (7629), 443-447, 2016 | 795 | 2016 |
| Blockade of the AHR restricts a Treg-macrophage suppressive axis induced by L-Kynurenine LF Campesato, S Budhu, J Tchaicha, CH Weng, M Gigoux, IJ Cohen, ... Nature communications 11 (1), 4011, 2020 | 266 | 2020 |
| Comprehensive cancer-gene panels can be used to estimate mutational load and predict clinical benefit to PD-1 blockade in clinical practice LF Campesato, R Barroso-Sousa, L Jimenez, BR Correa, J Sabbaga, ... Oncotarget 6 (33), 34221, 2015 | 238 | 2015 |
| Differential macrophage activation alters the expression profile of NTPDase and ecto-5′-nucleotidase RF Zanin, E Braganhol, LS Bergamin, LFI Campesato, AZ Filho, ... PLoS One 7 (2), e31205, 2012 | 123 | 2012 |
| Using LIBS to diagnose melanoma in biomedical fluids deposited on solid substrates: Limits of direct spectral analysis and capability of machine learning R Gaudiuso, E Ewusi-Annan, N Melikechi, X Sun, B Liu, LF Campesato, ... Spectrochimica Acta Part B: Atomic Spectroscopy 146, 106-114, 2018 | 76 | 2018 |
| Targeted APC activation in cancer immunotherapy to enhance the abscopal effect KD Suek N, Campesato LF, Merghoub T Frontiers In Immunology, 2019 | 58 | 2019 |
| In situ vaccination with defined factors overcomes T cell exhaustion in distant tumors DN Khalil, N Suek, LF Campesato, S Budhu, D Redmond, RM Samstein, ... The Journal of clinical investigation 129 (8), 3435-3447, 2019 | 50 | 2019 |
| iNOS regulates the therapeutic response of pancreatic cancer cells to radiotherapy PMR Pereira, KJ Edwards, K Mandleywala, LM Carter, FE Escorcia, ... Cancer research 80 (8), 1681-1692, 2020 | 44 | 2020 |
| High IL-1R8 expression in breast tumors promotes tumor growth and contributes to impaired antitumor immunity LF Campesato, APM Silva, L Cordeiro, BR Correa, FCP Navarro, ... Oncotarget 8 (30), 49470, 2017 | 35 | 2017 |
| Targeting phosphatidylserine enhances the anti-tumor response to tumor-directed radiation therapy in a preclinical model of melanoma S Budhu, R Giese, A Gupta, K Fitzgerald, R Zappasodi, S Schad, ... Cell reports 34 (2), 2021 | 33 | 2021 |
| Antiangiogenic therapy and immune checkpoint blockade go hand in hand LF Campesato, T Merghoub Annals of translational medicine 5 (24), 2017 | 28 | 2017 |
| Immunoengineering in glioblastoma imaging and therapy S Zanganeh, P Georgala, C Corbo, L Arabi, JQ Ho, N Javdani, ... Wiley Interdisciplinary Reviews: Nanomedicine and Nanobiotechnology 11 (6 …, 2019 | 22 | 2019 |
| Homocysteine decreases extracellular nucleotide hydrolysis in rat platelets RF Zanin, LFI Campesato, E Braganhol, MRC Schetinger, ... Thrombosis Research 125 (3), e87-e92, 2010 | 21 | 2010 |
| Overexpression of NTPDase2 in gliomas promotes systemic inflammation and pulmonary injury E Braganhol, RF Zanin, A Bernardi, LS Bergamin, AR Cappellari, ... Purinergic Signalling 8, 235-243, 2012 | 15 | 2012 |
| Increased p53 expression induced by APR-246 reprograms tumor-associated macrophages to augment immune checkpoint blockade A Ghosh, J Michels, R Mezzadra, D Venkatesh, L Dong, R Gomez, ... The Journal of Clinical Investigation 132 (18), 2022 | 12 | 2022 |
| NDRG4 promoter hypermethylation is a mechanistic biomarker associated with metastatic progression in breast cancer patients EHF Jandrey, RP Moura, LNS Andrade, CL Machado, LF Campesato, ... NPJ Breast Cancer 5 (1), 11, 2019 | 12 | 2019 |
| 31st annual meeting and associated programs of the society for immunotherapy of cancer (Sitc 2016): Part two: National harbor, md, USA. 9-13 November 2016 C Ager, M Reilley, C Nicholas, T Bartkowiak, A Jaiswal, M Curran, ... Journal for ImmunoTherapy of Cancer 4, 107-221, 2016 | 12 | 2016 |
| Isoform specific anti-TGFβ therapy enhances antitumor efficacy in mouse models of cancer A Gupta, S Budhu, K Fitzgerald, R Giese, AO Michel, A Holland, ... Communications Biology 4 (1), 1296, 2021 | 9 | 2021 |
| Innate immune checkpoints for cancer immunotherapy: expanding the scope of non T cell targets LF Campesato, CH Weng, T Merghoub Annals of Translational Medicine 8 (16), 2020 | 8 | 2020 |
| Targeting the IDO and TDO pathway through inhibition of the aryl hydrocarbon receptor J Tchaicha, K McGovern, LF Campesato, S Coma, XM Zhang, M Walsh, ... Cancer Research 78 (13_Supplement), 4723-4723, 2018 | 3 | 2018 |
